Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.5, Implies 32% Upside

• According to estimates from 16 analysts, Nurix Therapeutics, Inc. stock's average price target has risen from $31.44 to $32.5, with forecasts ranging from $23 to $45 per share
• Based on the Jul. 9 closing price, the updated target implies approximately 32% potential upside
• Consensus rating remains at “Buy” across 16 covering analysts, with 15 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Nurix Therapeutics, Inc. on the , and track all previous and future analyst recommendations for Nurix Therapeutics, Inc. in the dedicated .

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.